Continuous infusion of recombinant activated factor VII: Stability in infusion pump systems

Blood Coagulation and Fibrinolysis

Volumn 9, Issue SUPPL. 1, 1998, Pages

  Bonde, C ^a   Bech Jensen, M ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Activity; Continuous infusion; Microbiological contamination; Recombinant activated FVII; Stability

Indexed keywords

ENOXAPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLOOD CLOTTING; CONFERENCE PAPER; CONTINUOUS INFUSION; COST BENEFIT ANALYSIS; DRUG STABILITY; HEMOPHILIA; HEMOSTASIS; HUMAN; INFUSION PUMP; MICROCOCCUS LUTEUS; MOLECULAR WEIGHT; PATIENT CONTROLLED ANALGESIA; PRIORITY JOURNAL; STEADY STATE; TEMPERATURE; TREATMENT OUTCOME;

ANTICOAGULANTS; DRUG STABILITY; DRUG THERAPY, COMBINATION; FACTOR VIIA; FEASIBILITY STUDIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFUSION PUMPS; RECOMBINANT PROTEINS;

EID: 0031727811     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (1)

1. Schulman S, Bech Jensen M, Varon D, Keller N, Gitel S, Horoszowski H, et al. Feasibility of using recombinant factor VIIa in continuous infusion. Thromb Haemost 1996; 75:432-436.